odanacatib (MK-0822) / Merck (MSD)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
odanacatib (MK-0822) / Merck (MSD)
NCT00885170 / 2008-008257-30: A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)

Completed
2a
246
NA
Odanacatib, Placebo, Vitamin D3, Calcium
Merck Sharp & Dohme LLC
Osteoporosis
09/11
09/11
NCT00242476: A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)

Completed
2
216
US
MK0822A
Merck Sharp & Dohme LLC
Vitamin D Deficiency
07/06
07/06
NCT00397683 / 2006-005956-34: A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011)

Terminated
2
2
US, Europe, RoW
MK0822
Merck Sharp & Dohme LLC
Osteoarthritis
04/07
04/07
NCT00399802: A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Completed
2
43
NA
ZA, Zometa®, Odanacatib, MK-0822, Odanacatib matching placebo, ZA matching placebo
Merck Sharp & Dohme LLC
Breast Cancer, Metastatic Bone Disease
12/07
12/07
NCT00112437: A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)

Completed
2
399
NA
Odanacatib, MK-0822, Vitamin D3, Calcium Carbonate, Placebo
Merck Sharp & Dohme LLC
Osteoporosis
12/07
01/16
NCT00620113: Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)

Completed
2
287
NA
Odanacatib, MK-0822, Vitamin D3, cholecalciferol, Calcium carbonate, Placebo
Merck Sharp & Dohme LLC
Osteoporosis Postmenopausal
05/09
05/09

Download Options